UNLOCKING THE POTENTIAL OF CANNABINOID MEDICINE S INVESTOR PRESENTATION September 2019 21°T ANNUAL GLOBAL INVESTMEN CONFERENCE www.inmedpharma.com :IN :IMLFF DISCLAIMERS UNLOCKING THE POTENTIAL OF CANNABINOID MEDICINES 2 This presentation does not constitute an offering to sell or a solicitation of an offer to buy securities and the information contained herein is subject to the information contained in the Company's continuous disclosure documents on SEDAR at www.sedar.com. Information concerning the asset ...

InMed Pharmaceuticals, Inc. (IMLFF) Q2 2019 Results Earnings Conference Call February 12, 2019 1:00 PM ET Company Participants Josh Blacher - Chief Business Officer Eric Adams - President and CEO Jeff Charpentier - CFO Conference Call Participants Max Jacobs - Edison Group Jerry Isaacson - Roth Capital Operator Good morning and good afternoon. My name is Leonie, and I will be your conference operator today. At this time, I would like to welcome everyone to InMed's Second Quarter Earnings Conference Call. Al ...

U N L O C K I N G T H E P O T E N T I A L O F C A N N A B I N O I D M E D I C I N E S I N V E S T O R P R E S E N TAT I O N J a n u a r y 2 0 1 9 www.inmedpharma.com :IN :IMLFF DISCLAIMERS U N L O C K I N G C A N N A B I N O I D M E D I C I N E S 2 This presentation does not constitute an offering to sell or a solicitation of an offer to buy securities and the information contained herein is subject to the information contained in the Company's continuous disclosure documents on SEDAR at www.sedar.com. Info ...